Drug Approval | December 07, 2023
Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
The EU certification will support supplies of drug products registered in Europe, from this manufacturing site
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
USFDA issued issued Form 483 with nine observations, which will be addressed within stipulated time.
According to IQVIA sales data for the period ending January 2022, Vimpat tablets market achieved annual sales of approx. US $ 1.7 billion
The clinical research organisation located in Hyderabad is a USFDA inspected facility
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
Subscribe To Our Newsletter & Stay Updated
